Jéssica Wouk

Jéssica Wouk

Auto-generated profile, based on publicly available information

Jéssica Wouk

Midwest State University of Paraná, Brazil

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2017 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
FVFelipe Nathanael Coelho Vaz
Felipe Nathanael Coelho Vaz
BFBárbara Luisa Fermino
Bárbara Luisa Fermino
MHMaria Vaitsa Loch Haskel
Maria Vaitsa Loch Haskel
JWJéssica Wouk
Jéssica Wouk
GFGuilherme Barroso Langoni de Freitas
Guilherme Barroso Langoni de Freitas
Juliana Sartori BoniniJuliana Sartori Bonini
Juliana Sartori Bonini

Verified
Journal Article
Open access
PDF file
JLJosé Louzinho Lopes
José Louzinho Lopes
VQVinicius Seiki Takemura Quinteiro
Vinicius Seiki Takemura Quinteiro
JWJéssica Wouk
Jéssica Wouk
MDMaria Laura Darido
Maria Laura Darido
RDRobert F. H. Dekker
Robert F. H. Dekker
AOAlexandre Orsato
Alexandre Orsato
The infection of mammalian cells by enveloped viruses is triggered by the interaction of viral envelope glycoproteins with the glycosaminoglycan, heparan sulfate. By mimicking this carbohydrate, some anionic polysaccharides can block this interaction and inhibit viral entry and infection. As heparan sulfate carries both carboxyl and sulfate groups, this work focused on the derivatization of a (1→3)(1→6)-β-D-glucan, botryosphaeran, with these negatively-charged groups in an attempt to improve its antiviral activity. Carboxyl and sulfonate groups were introduced by carboxymethylation and sulfonylation reactions, respectively. Three derivatives with the same degree of carboxymethylation (0.9) and different degrees of sulfonation (0.1; 0.2; 0.4) were obtained. All derivatives were chemically characterized and evaluated for their antiviral activity against herpes (HSV-1, strains KOS and AR) and dengue (DENV-2) viruses. Carboxymethylated botryosphaeran did not inhibit the viruses, while all sulfonated-carboxymethylated derivatives were able to inhibit HSV-1. DENV-2 was inhibited only by one of these derivatives with an intermediate degree of sulfonation (0.2), demonstrating that the dengue virus is more resistant to anionic β-D-glucans than the Herpes simplex virus. By comparison with a previous study on the antiviral activity of sulfonated botryosphaerans, we conclude that the presence of carboxymethyl groups might have a detrimental effect on antiviral activity.

1 January 2020 in Fisioterapia em Movimento
Verified
Journal Article
Open access
PDF file
SSSuzane Cristina Santos
Suzane Cristina Santos
AFAndersom Ricardo Fréz
Andersom Ricardo Fréz
JRJoão Afonso Ruaro
João Afonso Ruaro
JWJéssica Wouk
Jéssica Wouk
CDChristiane Riedi Daniel
Christiane Riedi Daniel
Introduction: Oncological patients who are submitted to surgical procedures might have postoperative pulmonary complications (PPCs). Thus, preoperative physical conditions must be considered, since it is an important predictor of postoperative development. Objective: The purpose of this study was to analyze the risk factors for postoperative pulmonary complications that might compromise the recovery after oncologic surgery. Method: The present observational transversal study was made between March and October of 2015. Patients diagnosed with cancer were analyzed to determine pulmonary and functional condition and to identify the risk factors for the development of PPCs. The post-surgery recovery was followed through medical records. Data collected from patients’ analyses was correlated with post-surgery development. Results: Thirty patients were analyzed. A negative and moderate correlation was found between maximal inspiratory pressure (MIP) and PPCs (r=-0.39; p=0.032). A positive correlation between the time of permanence in the Intensive Care Unit (ICU) and hospitalization days (r=0.40; p=0.02) was observed. Correlations between PPCs and mechanical ventilation (r=0.36; p=0.04) and hospitalization days (r=0.40; p=0.02) were also noticed in the present study. Conclusion: PPCs might prejudice post-surgery outcome. The greater are physical condition and pulmonary functions of the patients before surgery, the better is their recovery.

1 January 2024 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
PDF file
RPRicardo A. Pereira
Ricardo A. Pereira
AHAlbimara Hey
Albimara Hey
AJAline B. DE Jesus
Aline B. DE Jesus
AMAline T. Marin
Aline T. Marin
FFFernanda Fiorini
Fernanda Fiorini
CMCarlos Ricardo Maneck Malfatti
Carlos Ricardo Maneck Malfatti
This article reports the development of a beer made with Baccharis dracunculifolia and its application in an experimental model of diabetes. Initially, the production of the beverage was standardized in order to incorporate the plant extract properly. Next, the beer was analyzed by the UHPLC-MS to identify the substances present. Among others, caffeic acid (5.85 mg / L), m-coumaric acid (5.16 mg / L), pinocembrin (2.99 mg / L), chrysin (10.86 mg / L), myricetin (1.73 mg / L) and spathulenol (9.30 mg / L) were found. Animal tests indicate improvement in biochemical and histological parameters of STZ-induced Wistar rats that ingested the beer made with the plant. The antidiabetic potential of this beverage was observed in the different tests that evaluated insulin resistance and the decrease of the clinical manifestations of diabetes in animals. The use of the drink as an adjunct in clinical treatments for DM2 may be useful, especially in suppressing the oxidative damage caused by the disease.

29 November 2017 in F1000Research
Verified
Journal Article
Open access
PDF file
FVFelipe Nathanael Coelho Vaz
Felipe Nathanael Coelho Vaz
LTLuana Bortoluzzi Trombim
Luana Bortoluzzi Trombim
GFGuilherme Barroso L. de Freitas
Guilherme Barroso L. de Freitas
MHMaria Vaitsa Loch Haskel
Maria Vaitsa Loch Haskel
GSGiovana dos Santos
Giovana dos Santos
Juliana Sartori BoniniJuliana Sartori Bonini
Juliana Sartori Bonini
Background: Elderly patients frequently have concomitant diseases, triggering the necessity of utilizing several different medications, which can cause adverse events associated with therapy, called polypharmacy. This study aimed to evaluate the main concomitant diseases with Alzheimer's disease (AD) and discuss possible interactions between drugs utilized to treat dementia and its comorbidities, and indicate safe medicines for patients with AD. Methods: 41 individuals with AD who withdraw medicines for dementia from the Brazilian public health system (SUS) participated in this study. Data collection was performed using three questionnaires: 1) Clinical Dementia Rating, to verify disease stage; 2) Mini–mental state examination, to measure cognitive impairment; and 3) Sociodemographic analysis, to evaluate concomitant diseases, utilized drugs, drug-drug interactions, among other demographic variables. Statistical analyses were performed using SPSS and data was presented as relative frequency. Results: The results of this study showed that the most frequent concomitant diseases with AD are: systemic arterial hypertension, depression, diabetes mellitus, and hypercholesterolemia. Polypharmacy was observed in 95.12% of patients. The pharmacologic classes that presented interactions with AD medications were anxiolytics, antidepressants, antipsychotics, antihypertensives, and antidiabetics. Conclusion: In the present study, polypharmacy in patients with AD and other concomitant diseases has been characterized. The average number of drugs that these patients ingested was seven per day, and this leads to drug interactions, which are potentially damaging to the body. Consequently, we have tried to reduce these interactions, by suggesting drugs that are safer, for example furosemide instead of amlodipine to treat hypertension.

1 April 2018 in Cadernos de Prospecção
Verified
Journal Article
Open access
PDF file
NPNilane Françoise Patel
Nilane Françoise Patel
BSBruno Moreira Soares
Bruno Moreira Soares
DRDaniele Fernanda Renzi
Daniele Fernanda Renzi
APAndressa Razera Pezoti
Andressa Razera Pezoti
JWJéssica Wouk
Jéssica Wouk
FVFelipe Nathanael Coelho Vaz
Felipe Nathanael Coelho Vaz
O Diabetes mellitus (DM) destaca-se como um problema de saúde pública mundial. Diante disso, várias espécies de plantas vêm sendo utilizadas para tratar e/ou combater os sintomas do DM. O objetivo deste estudo foi avaliar os efeitos da ingestão subcrônica do extrato de Baccharis dracunculifolia, em modelo animal de DM. Foram utilizados 56 ratos machos da linhagem Wistar, tratados por 28 dias. O modelo de DM tipo I foi induzido pela administração de 60 mg/kg de estreptozotocina. O grupo CB demonstrou 14,8% (p<0.05) menor consumo de ração que o grupo DB200. Quanto à ingestão hídrica, o grupo CDT teve maior ingesta (44,1%; p<0.05) com relação aos grupos tratados. Na glicemia capilar em jejum e pós-prandial, os grupos tratados apresentaram redução de 54,3% a 63,4% ao jejum e 37,9% a 45% no pós-prandial. Conclui-se que o extrato metanólico de B. dracunculifolia reduziu os níveis glicêmicos em ratos diabéticos tipo I.